The biggest technical challenge for adaptive deep brain stimulation (aDBS) is how small brain signals are, Medtronic's Scott ...

The global extracorporeal membrane oxygenation machine market is on a growth trajectory, with revenue anticipated to reach ...

For the one million people diagnosed with Parkinson's disease in the United States, Medtronic plc (NYSE:MDT), a global leader in healthcare technology, proudly announces U.S. Food and Drug ...

The FDA has approved BrainSense, an adaptive deep brain stimulation system that can adjust therapy for Parkinson’s disease in ...

The FDA approves BrainSense Adaptive deep brain stimulation and electrode identifier technology for the treatment of ...

The FDA has approved Medtronic's Brainsense Adaptive deep brain stimulation for patients with Parkinson's disease. The technology is designed to adjust therapy in real time based on a patient's brain ...

This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them. The NASDAQ composite index has been scorching hot since ...

When it comes to sleep apnea there are several treatments for a patient. One of those treatments includes outpatient surgery.

U.S. Deep Brain Stimulation In Parkinson’s Disease Market Dublin, Feb. 25, 2025 (GLOBE NEWSWIRE) -- The "U.S. Deep Brain Stimulation In Parkinson's Disease Market Size, Share & Trends Analysis ...

Centinel Spine signed a senior secured loan agreement with SLR Capital Partners for $60 million, according to a Feb. 26 news release.

In the fourth episode of The Deep End, Jon Nelson and others describe dealing with emotions they haven’t felt in a long time.

Introduction to the Nerve Repair MarketThe nerve repair market is a rapidly growing sector within the healthcare and medical ...